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Background: Endovascular Aortic aneurysm Repair (EVAR) offers the potential for a reduced hospital stay.
The aim of this study was to identify patients suitable for short stay EVAR (SEVAR) with a single night in
hospital and document their outcome.
Method: Patients for EVAR were assessed prospectively for SEVAR over a 21-month period using UK Day
Surgery Guidelines. Joint anaesthetic and surgical approval were necessary for these patients to be
included in this vascular pathway. Patients were admitted on the day of surgery with a designated care
protocol for discharge the day after.
Results: 101 patients were assessed for SEVAR. 33 (33%) patients met the criteria for SEVAR and 27 of
these (81%) were successfully discharged one day post-operatively. Total SEVAR median LOS was one day
(IQR ¼ 0) versus four days (IQR ¼ 2) for the standard EVAR group (P < 0.0001) reducing costs from
£13,360 (CI ¼ 1074) to £9844 (CI ¼ 628). Increased utilisation of SEVAR during the study period led to
reduced overall average EVAR costs, £12,102(CI ¼ 795) to £10,330(CI ¼ 757).
Conclusion: SEVAR protocol reduces hospital stay for selected patients. The outcomes from a larger cohort
of such patients require further study. This would identify whether SEVAR could be expanded to more
patients.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Background
Endovascular aortic aneurysm repair (EVAR) is a well-
established modality for treating elective abdominal aortic aneu-
rysms (AAA). Although AAA patients usually have signiﬁcant co-
morbidities, EVAR still offers the potential for a reduced hospital
length of stay (LOS) and reduced morbidity compared to open
surgery.1e4 In recent series a mean length of stay for EVAR has been
documented at between 2.5 and 2.8 days.3,5,6 Protocols for day of
surgery admission are widespread in the UK now.7 To reduce
hospital stay to a minimum, patients required assessment to
identify those that could safely be admitted on the day of surgery
and discharged the next day Fig. 1.
The Royal College of Anaesthetists has published criteria for
successful day surgery. Their guidelines cover not only pre-
assessment medical selection but extend to intra-operative care,; fax: þ44 (0) 1223 216679.
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ciety for Vascular Surgery. Publishpost-operative discharge instructions, follow up and unit
management.8 There is emphasis on leadership from a nominated
clinical lead, trained pre-assessment teams, anaesthetists with
a speciﬁc interest in day surgery and audit and governance.
Many of these factors can be applied to EVAR procedures to help
reduce LOS. Breast, Endocrine and Hepato-Biliary surgery have all
successfully implemented day case practice for selected proce-
dures. Thyroidectomy, breast cancer surgery and laparoscopic
cholecystectomy have all been performed on a day case or short
stay basis with low complication rates and no increase in re-
admission rates.9e11 Careful patient selection is stressed as the
key to achieve successful outcomes.
The hypothesis underlying this study was that for selected
patients the LOS could be reduced further with a single overnight
stay. The aim of this study was to identify patients suitable for short
stay EVAR (SEVAR) using recognised day surgery selection criteria,
and document their outcome.
Method
This was a prospective study of all patients undergoing elective
infrarenal AAA EVAR from 01/09/2009 to 01/06/2011. A total of 101
patientswere entered into the study. The overall unit activity duringed by Elsevier Ltd. All rights reserved.
Figure 1. Comparison between the length of stay for both SEVAR and standard EVAR
groups. Vertical axis number of patients. LOS is categorized into 1, 2e3, 4e5, 6e10 and
>10 days. No patients were discharged within the ﬁrst post-operative day from the
standard EVAR group.
Table 2
Baseline and procedural characteristics for both SEVAR and Non-SEVAR groups.
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aneurysm repairs, 3 Fenestrated EVARs, 5 Aorto Uni-iliac grafts and
8 emergency EVARs. Fenestrated and branched procedures were
excluded from the analysis since they were not considered for
SEVAR due to the longer and more complex procedure.
At the pre-assessment visit prior to EVAR, the vascular specialist
nurse (VSN) screened patients for SEVAR suitability according to
the criteria summarized in (Table 1). A Vascular anaesthetist was
informed of the selected patients for approval. All SEVAR patients
were given an information leaﬂet explaining the recovery process
and planned discharge the day after surgery. After patient’s
agreement and anaesthetic approval, patients were admitted on
the day of EVAR surgery using a speciﬁc SEVAR integrated care
pathway (ICP). Post-operatively patients were nursed and moni-
tored on a vascular ward. Patients were assessed on the morning of
the ﬁrst post-operative day for discharge. Early follow up was by
telephone from the VSN. Clinic follow up was at six weeks.
Details of the EVAR procedures were entered prospectively onto
an EVAR database. The hospital costing and administration data-
base (Cambridge Hospital Evaluation and Quality System) was used
to calculate direct procedural costs incurred from the cost of theatre
time, ward, staff and investigations requested post-operatively.
All EVAR procedures were performed in a vascular operating
theatre with a mobile C-arm image intensiﬁer and radiolucent
table. Bilateral open common femoral artery cutdown was used in
all cases. All patients had a general anaesthetic. Urinary tract
catheterisation was avoided. Oral paracetamol and opiates were
used for post-operative analgesia.
Statistics
Continuous, normally distributed variables are reported as
means with SD and 95% conﬁdence intervals (CI). Medians andTable 1
Patient selection criteria for SEVAR.
Favourable anatomy (Excluding Fenestrated, Uni-iliac and internal iliac artery
embolization)
ASA Grade 3 or below
BMI < 35
Dyspnoea grade 2 or less
No Myocardial infarction in the last 6 months
Angina classiﬁcation 2 or below
No CVA/TIA within last year
Non-Diabetic (excluding diet controlled)
No signiﬁcant renal impairment (eGFR > 60 ml/min)
No advanced liver disease
No signiﬁcant cognitive impairment
Carer support available post-operatively
Transport available peri-operativelyInterquartile ranges (IQR) are used for skewed distributions.
Categorical variables are given as absolute number (%), unless
stated otherwise. The ManneWhitney U test was used for
comparisons of continuous variables. All p-values are two-
sided.Results
101 consecutive patients attended pre-assessment for an elec-
tive EVAR during the 21months. Therewere 94 (93%)males and the
mean age was 76 (SD  7.1) years. The mean aneurysm diameter
was 6.0 cm (SD  1.0). Sixty eight (67%) patients were not selected
for SEVAR as they did not meet one or more criteria (Table 2).
Twenty eight (41%) were due to signiﬁcant medical co-morbidities
including unstable ischaemic heart disease (9), chronic obstructive
pulmonary disease (9) and chronic kidney disease (CKD) requiring
pre-operative intravenous hydration (10). Ten (15%) procedures had
technical factors that were felt to require a longer hospital stay,
(cross-over graft, femoral endarterectomy, iliac occlusive disease).
Thirteen (19%) required embolization of the internal iliac artery.
Our unit policy is to perform these 1e2 days pre-operatively during
the same admission as for the EVAR. Eight (12%) were missed and
not assessed by the VSN in the pre-assessment clinic. Nine (13%)
had transport difﬁculties to hospital.
Thirty three patients (33%) were selected for SEVAR as they
met all criteria and 27 (81%) were successfully discharged after one
night in hospital. Six (19%) had an unplanned extended stay in
hospital. One patient had unforeseen transport issues and stayed
for 2 days, 2 patients with social care problems stayed 2 days, 2
patients had unexpected difﬁculty in graft implantation and stayed
for 2 days and 1 patient had urinary retention and haematuria post-
operatively and stayed for 7 days. Over the duration of the study the
proportion of patients selected for SEVAR increased. In the ﬁrst half
of the study period 30% were selected for SEVAR and in the second
half of the study this has increased to 45%. Median LOS in the SEVAR
group was one (IQR ¼ 0) day compared to 4 (IQR ¼ 2) days in the
standard EVAR group. (P < 0.001).
None of the SEVAR patients had a re-admission to hospital
within 30 days after successful discharge from hospital. None of the
patients in the standard EVAR group with an American Society of
Anaesthesiologists (ASA) grade of >3 were discharged within 3
days of surgery. No patients in the standard EVAR group were
discharged after one night in hospital.
We analysed the costs for both groups of patients. The average
cost of stay for the standard EVAR group was £13,360 (SD ¼ 4520,
CI ¼ 1074) compared to £9844 (SD ¼ 1840, CI ¼ 628) for theSEVAR Non-SEVAR
Baseline characteristics
Mean age 76 (SD ¼ 6) 76 (SD ¼ 7)
Mean aneurysm size (cm) 6 (SD ¼ 0.8) 6 (SD ¼ 1)
Median ASA 2 (IQR ¼ 1) 3 (IQR ¼ 2)
Median LOS (days) 1 (IQR ¼ 0) 4 (IQR ¼ 2)
Mean Cost (Sterling pounds) £9844 (CI ¼ 628) £13,360 (CI ¼ 1074)
Total patients 33 68
Procedural characteristics
Anaesthesia GA 33 66
Anaesthesia LA/Regional 0 2
Bifurcated graft 33 63
Aorto-Uniliac graft 0 5
Femoral Endarterectomy 0 5
Internal iliac embolization 0 13
Vertical incision 33 68
Horizontal incision 0 0
N. Al-Zuhir et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 662e665664SEVAR group (P < 0.0001). Furthermore, we analysed the cost of
stay for all patients in the ﬁrst half and the second half of the study
to assess the beneﬁt of increased adoption of SEVAR (45% vs. 30%).
The average total EVAR cost in the ﬁrst half was £12,102 (SD¼ 4017,
CI ¼ 795) compared to £10,330 (SD ¼ 2892, CI ¼ 757)
(P < 0.0001) in the second half of the study period. This increase in
SEVAR patients recruited was due an increase in the utilization of
SEVAR protocol in the unit.Discussion
EVAR is associated with reduced morbidity and length of stay in
hospital. This study has shown that selecting patients for SEVAR
can further reduce hospital stay, with associated cost savings. This
short stay protocol depends on ensuring a seamless discharge back
into the community and identifying any pre-operative variables
that may hinder a short stay.
Other surgical specialities have introduced similar short stay
protocols for selected procedures with good outcomes, low re-
admission and complication rates.9e11 Our experience with
SEVAR mirrors these conclusions from other specialities. Careful
selection is vital and should involve not only medical factors but
also social care and transport issues. Another common theme in
these short stay protocols is good patient information regarding
discharge and post-operative contacts. When patients are prepared
for early discharge in advance it becomes their expectation.
One unpredictable area we found was urinary retention. One of
our SEVAR patients had a long stay of 7 days due to this compli-
cation. Elkhodair et al. have shown that using an International
Prostate Symptoms Score (IPSS) for patients undergoing arthro-
plasty they were able to identify those at risk for post-operative
urinary retention.12 High risk patients can have an altered
management plan to facilitate early discharge such as intentional
catheterisation with planned community removal.
Pre-existing chronic kidney disease and pre-procedural
hydration prevented SEVAR in 10 of our patients with an
eGFR < 60 ml/minute. Our policy was to hydrate these patients
overnight with intravenous ﬂuids and hence they were excluded
from SEVAR. Published guidance from Goldfarb et al.13 offers
the potential to hydrate patients with an eGFR between 30 and
60 ml/min for just 1 h pre-operatively and 3 h post-operatively.
Using this protocol these patients could be included in a SEVAR
programme increasing the proportion selected. Overnight hydra-
tion would still be recommended for patients with an
eGFR < 30 ml/min.13
Two other measures to consider for SEVAR would be local or
regional anaesthesia and percutaneous femoral access. Neither of
these techniques were employed in this study but require consid-
eration to increase the proportion of patients eligible for a SEVAR
programme. EVAR under local anaesthesia (LA), including ASA > 3
patients, has been successfully reported.14e17 This was claimed to
reduce LOS, although no randomised comparisons exist to conﬁrm
this. LA EVAR can still be quite demanding requiring experienced
anaesthetic support to control patient anxiety and pain while
performing the procedure. Edwards et al. reported less post-
operative LOS and pulmonary complications when using spinal/
local anaesthesia versus general anaesthesia (P < 0.001) looking at
elective EVAR procedures in North America.6
Percutaneous access could also assist short stay EVAR for
patients without a high BMI or heavily calciﬁed femoral vessels.
Malkawi et al. have shown reduced operative time and fewer access
related complications with percutaneous access.18 However none
of the SEVAR patients in this study were delayed from discharge by
wound problems or were re-admitted with wound issues.The main cost drivers in aneurysm repair patients are length of
stay (LOS), time in the intensive-care unit, blood product usage
and EVAR device costs.19 Elective EVAR rarely requires ITU stay or
blood products. Device costs are outside of physician control. The
remaining clinical cost variable is therefore LOS. In our study,
SEVAR patients median LOS was 1 day (IQR ¼ 0) compared to 4
days (IQR ¼ 2) for standard EVAR. This reduced procedural costs
from £13,360 (SD ¼ 4520, CI ¼ 1074) to £9844(SD ¼ 1840,
CI ¼ 628) for the SEVAR group (P < 0.0001). The overall impact
of this saving for the vascular unit depends on the number of
SEVAR cases performed. Average procedure costs fell in our unit
as we performed proportionately more SEVAR cases, rising from
30% in the ﬁrst half of the study period (mean cost £12,102
(SD ¼ 4017, CI ¼ 795)) to 45% in the second half of the study
period (mean cost £10,330 (SD ¼ 2892, CI ¼ 757)). This gain
occurred without any associated increase in hospital re-admission
after discharge.
This study was a clinical feasibility study, assessing the success
of introducing a speciﬁc short stay programme into daily practice in
a single unit. It was not a controlled comparison of outcomes with
andwithout SEVAR in the same time period.We felt that this would
be too difﬁcult to do in a blinded fashion in the same institution.
Clearly patients selected for short stay using day case criteria will
have fewer co-morbidities, better social support, and have the
potential to achieve a short LOS. The important ﬁnding of this study
was that an established pathway is required in order for this
potential to be realised. Prior to the commencement of this
protocol, such patients were not prepared for short stay, and failed
to achieve early discharge.
Conclusion
In conclusion SEVAR protocol can reduce hospital stay for
selected patients. With experience we have extended the use of
SEVAR to more patients with modiﬁed, less restrictive selection
criteria. The outcome from a larger cohort of such patients requires
further study to deﬁne the full potential for SEVAR to reduce LOS
and costs.
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